“elan” Archives

in
Entry Author Date Location
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
West Coast Biotech Roundup: PCSK9, Amgen, SeaGen, Twist, Serenus 06/11/15 Seattle
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
Aiming to Boost Innovation, Trinity Fine-Tunes Its Tech Transfer 10/30/14 National
Ex-Elan Trio Grabs Their Former Employer’s Kinase Inhibitor Program 09/29/14 San Francisco
Hunting For Brain Plaques, Neurophage Turns to a Virus 01/31/14 Boston
Proteostasis, Biogen Team up on Protein Homeostasis Drugs 12/09/13 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
East Coast Life Sciences Roundup: Sarepta, Agios, Gerngross, & (Much) More 07/26/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Boston Roundup: Biogen Idec, Cloudant, NEA, eClinicalWorks, & More 02/06/13 Boston
Prothena of South San Francisco Gets Head Start as Elan Spinoff 01/09/13 San Francisco
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
In Wake of Alzheimer’s Disaster, Wall Street Revisits Pfizer and J&J 08/08/12 New York
In a Detour From Device Strategy, Zogenix Edges Closer to New Drug Application 10/27/11 San Diego
Immune Design Rakes In Another $11M From Prior VC Round 10/05/11 Seattle
Harvard Accelerator Program, Proving Its Mettle with Startups and Pharma Partnerships, Looks to Raise Big New Fund 08/11/11 Boston
Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News 06/01/11 Boston
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs 05/25/11 Boston
Alkermes Acquires Elan Drug Manufacturing Unit for $960M 05/09/11 Boston
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO 04/27/11 Seattle
Hitting the Target, Missing the Mark: How Targeted Therapies Have Left Patients Wanting 04/14/11 Seattle
Report: Layoffs Hit Elan 01/26/11 San Francisco
Biogen Aims to Reduce PML Risk 12/22/10 Boston
San Diego’s Zogenix Moving Fast to Commercialize Drug-and-Device Combo 08/17/10 San Diego
Former Idera Pharma CEO at Helm of AesRx, New Startup With Sickle Cell Drug 01/05/10 Boston
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News 10/28/09 Boston
Biogen Shares Drop as Tysabri PML Cases Climb to 23, Europe May Seek Drug ‘Holiday’ 10/23/09 Boston
Tysabri’s Tally of PML Cases Reaches 13 09/17/09 Boston
Page 1 of 3 next page »